M W Sung

Summary

Affiliation: Mount Sinai School of Medicine
Country: USA

Publications

  1. ncbi Intratumoral adenovirus-mediated suicide gene transfer for hepatic metastases from colorectal adenocarcinoma: results of a phase I clinical trial
    M W Sung
    Division of Medical Oncology, Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA
    Mol Ther 4:182-91. 2001
  2. ncbi Combination of cytotoxic-differentiation therapy with 5-fluorouracil and phenylbutyrate in patients with advanced colorectal cancer
    Max W Sung
    Division of Hematology Oncology, Department of Medicine, Box 1129 Mount Sinai School of Medicine, One Gustave L Levy Place, New York, New York 10029, USA
    Anticancer Res 27:995-1001. 2007
  3. ncbi Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis
    Sasan Roayaie
    Recanati Miller Transplantation Institute, Department of Medicine, Mount Sinai Medical Center, Mount Sinai NYU Health System, New York, NY 10029, USA
    Liver Transpl 10:534-40. 2004
  4. ncbi Intratumoral delivery of adenovirus-mediated interleukin-12 gene in mice with metastatic cancer in the liver
    Max W Sung
    Carl C. Icahn Institute for Gene Therapy and Molecular Medicine, Mount Sinai School of Medicine, 1425 Madison Avenue, Room 13-20, New York, NY 10029, USA
    Hum Gene Ther 13:731-43. 2002
  5. ncbi Unresectable squamous cell carcinoma of donor origin treated with immunosuppression withdrawal and liver retransplantation
    Sander Florman
    The Recanati Miller Transplantation Institute, New York, NY, USA
    Am J Transplant 4:278-82. 2004

Detail Information

Publications5

  1. ncbi Intratumoral adenovirus-mediated suicide gene transfer for hepatic metastases from colorectal adenocarcinoma: results of a phase I clinical trial
    M W Sung
    Division of Medical Oncology, Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA
    Mol Ther 4:182-91. 2001
    ..0x10(13) virus particles per patient, and can provide the basis for future clinical trials involving intratumoral adenoviral vector injection...
  2. ncbi Combination of cytotoxic-differentiation therapy with 5-fluorouracil and phenylbutyrate in patients with advanced colorectal cancer
    Max W Sung
    Division of Hematology Oncology, Department of Medicine, Box 1129 Mount Sinai School of Medicine, One Gustave L Levy Place, New York, New York 10029, USA
    Anticancer Res 27:995-1001. 2007
    ..Phenylbutyrate (PB), a histone deacetylase inhibitor (HDACi), has been shown in laboratory studies to potentiate growth inhibition by 5-fluorouracil (FUra) of human colon carcinoma cells...
  3. ncbi Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis
    Sasan Roayaie
    Recanati Miller Transplantation Institute, Department of Medicine, Mount Sinai Medical Center, Mount Sinai NYU Health System, New York, NY 10029, USA
    Liver Transpl 10:534-40. 2004
    ..Nonetheless, some patients with recurrence can be expected to live for a considerable period of time. Recurrent disease should be treated surgically when possible, because surgery is independently associated with longer survival...
  4. ncbi Intratumoral delivery of adenovirus-mediated interleukin-12 gene in mice with metastatic cancer in the liver
    Max W Sung
    Carl C. Icahn Institute for Gene Therapy and Molecular Medicine, Mount Sinai School of Medicine, 1425 Madison Avenue, Room 13-20, New York, NY 10029, USA
    Hum Gene Ther 13:731-43. 2002
    ..These results support the cautious testing in patients with hepatic metastases of adenovirus mediated IL-12 gene delivery by intratumoral injection...
  5. ncbi Unresectable squamous cell carcinoma of donor origin treated with immunosuppression withdrawal and liver retransplantation
    Sander Florman
    The Recanati Miller Transplantation Institute, New York, NY, USA
    Am J Transplant 4:278-82. 2004
    ..More than 2 years later she remains disease-free with complete pathological remission. This is the only reported case of squamous cell carcinoma of donor origin arising in a transplanted liver...